Prepared by a licensed compounding pharmacy. Not FDA-approved.
Tirzepatide is a GLP-1 and GIP medication. It acts on GLP-1 and adds a second hormone pathway called GIP, which can affect appetite and blood sugar. LightWeightMD offers compounded tirzepatide, prepared by a licensed Florida compounding pharmacy and prescribed only after a live consultation with a licensed provider. Compounded medications are not FDA-approved.
Treatment starts at a low dose and steps up over roughly four months. The slow ramp is deliberate: most side effects appear when a dose climbs too fast, and giving your body time to adjust keeps the majority of people comfortable. Your provider sets your actual schedule.
Tirzepatide acts on the GLP-1 pathway and adds a second hormone pathway called GIP, which can affect appetite and blood sugar. Compounded medications are not FDA-approved.
Nausea, constipation, and fatigue are the most commonly reported, and usually ease as your body adjusts. They tend to show up after a dose increase. Smaller meals, eating slowly, and drinking more water than feels necessary are the three habits that help most.
Contact your provider promptly for severe abdominal pain that will not let up, persistent vomiting, or signs of an allergic reaction. These are uncommon but should be taken seriously.
Compounded tirzepatide is $300 per month through LightWeightMD, including medication, shipment, and ongoing physician oversight. Your first month is $275. The price stays $300 until 15.0 mg, when it becomes $340. The 12.0 mg step lasts 5 weeks. There is no membership fee. See the schedule.
Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, or quality. Read our guide to compounding for the full picture.
Comparing options? Read about compounded semaglutide.